IP Library Granted Patent US 7,396,467
Granted Patent B2
US 7,396,467 · App. 10/964,269 · Granted Jul 8, 2008

Method of preparing a chromatography matrix

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,396,467
App. No.
10/964,269
Granted
Jul 8, 2008
Kind
B2
Abstract

The present invention relates to a method of preparing a porous cross-linked polysaccharide chromatography matrix, which comprises to provide an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack; to provide essentially spherical droplets of the substituted polysaccharide solution; to form a gel of the substituted polysaccharide solution; and to cross-link the gel by adding a cross-linking agent. The invention also encompasses a chromatography column packed with a matrix so produced as well as use thereof in e.g. protein purification.

Claims (24)

1. A method of preparing a chromatography column, which method comprises the steps of

(a) providing an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack;

(b) providing essentially spherical droplets of the polysaccharide solution;

(c) forming a gel of the essentially spherical droplets;

(d) cross-linking the gel by adding a cross-linking agent to form a porous cross-linked polysaccharide chromatography matrix; and

(e) packing said porous cross-linked polysaccharide chromatography matrix in a chromatography column;

wherein said porous cross-linked polysaccharide chromatography matrix allows higher flow rate of said column than matrix made from non-substituted polysaccharide.

2. The method of claim 1 , wherein the groups which are not susceptible to nucleophilic attack are selected from the group consisting of ethers, esters, amides and xanthates.

3. The method of claim 1 , wherein the dissolved substituted polysaccharide is emulsified in an organic solvent.

4. The method of claim 1 , wherein a porogen is added before gelation.

5. The method of claim 1 , wherein the aqueous solution of polysaccharide is provided by heating and the gel is formed by reducing the temperature.

6. The method of claim 1 , wherein the polysaccharide is agarose.

7. The method of claim 1 , wherein the gelling point of the polysaccharide is at least about 1° C. lower than that of the corresponding non-substituted polysaccharide.

8. The method of claim 1 , further comprising cleaving off the groups which are not susceptible to nucleophilic attack, after cross-linking.

9. The method of claim 8 , wherein the groups which are not susceptible to nucleophilic attack are ester groups cleaved off by hydrolysis.

10. The method of claim 1 , which further comprises attaching chromatography ligands to hydroxyl groups of the gelled polysaccharide after cross-linking thereof.

11. A method of preparing a chromatography column, which method comprises the steps of

(a) providing an aqueous solution of a gellable polysaccharide;

(b) substituting part of the hydroxyl groups of the polysaccharide in the aqueous solution with groups that are not susceptible to nucleophilic attack once substituted;

(c) providing essentially spherical droplets of the substituted polysaccharide solution from step (b);

(d) forming a gel of the essentially spherical droplets;

(e) cross-linking the gel by adding a cross-linking agent to form a porous cross-linked polysaccharide chromatography matrix; and

(f) packing said porous cross-linked polysaccharide chromatography matrix in a chromatography column;

wherein said porous cross-linked polysaccharide chromatography matrix allows higher flow rate of said column than matrix made from non-substituted polysaccharide.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2005
From: BERG, HANS; BUCKLEY, DAVID; BRANNHOLM, MARIA; HAGVALL, ANDERS; IHRE, HENRIK; HOLMGREN, EVA; LARSSON, ANDERS; LINDSTROM, DAG
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015663/0001 →